rFVIIa – Its Thrombogenicity
- 1 January 2000
- journal article
- letter
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 84 (09) , 522-523
- https://doi.org/10.1055/s-0037-1614059
Abstract
No abstract availableFunding Information
- Health Services Administration (MCB-360001)
- Health and Human Services (HS-30567)
- Regional Comprehensive Hemophilia Diagnostic and Treatment Center
- Margie Boas Fund
- International Hemophilia Training Center of the World Federation of Hemophilia
- Polly Annenberg Levee Hematology Center
- Department of Medicine, Mount Sinai School of Medicine of the City University (5MO1RR00071)
- Mount Sinai General Clinical Research Center from the National Center for Research Resources
- National Institutes of Health
This publication has 3 references indexed in Scilit:
- Safety, efficacy and lessons from continuous infusion with rFVIIaHaemophilia, 1998
- Recombinant Activated Factor VII in the Treatment of Bleeding Episodes in Patients With Inherited and Acquired Bleeding DisordersTransfusion Medicine Reviews, 1993
- Efficacy and safety of vapor‐heated anti‐inhibitor coagulant complex in hemophilia patients. FEIBA Study GroupTransfusion, 1990